See more : Peoples Ltd. (PPLL) Income Statement Analysis – Financial Results
Complete financial analysis of Unrivaled Brands, Inc. (UNRV) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Unrivaled Brands, Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
You may be interested
- VEREIT, Inc. (VER) Income Statement Analysis – Financial Results
- Graph Blockchain Inc. (GBLC.CN) Income Statement Analysis – Financial Results
- Electricity Generating Public Company Limited (EGCO.BK) Income Statement Analysis – Financial Results
- Earth Infinity Co.Ltd. (7692.T) Income Statement Analysis – Financial Results
- Izhstal PAO (IGST.ME) Income Statement Analysis – Financial Results
Unrivaled Brands, Inc. (UNRV)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.unrivaledbrands.com
About Unrivaled Brands, Inc.
Unrivaled Brands, Inc. cultivates, produces, distributes, and retails medical and adult use cannabis products in California, Oregon, and Nevada. It also operates medical marijuana retail and adult use dispensaries, cultivation, and production facilities. The company was formerly known as Terra Tech Corp. and changed its name to Unrivaled Brands, Inc. in July 2021. Unrivaled Brands, Inc. was founded in 2010 and is based in Santa Ana, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 52.02M | 47.67M | 14.29M | 28.05M | 31.33M | 35.80M | 25.33M | 9.98M | 7.09M | 2.13M | 552.58K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 35.12M | 35.71M | 10.69M | 13.40M | 18.90M | 30.32M | 22.76M | 8.96M | 6.94M | 2.04M | 451.71K | 0.00 | 0.00 | 0.00 |
| Gross Profit | 16.90M | 11.97M | 3.60M | 14.65M | 12.43M | 5.48M | 2.57M | 1.02M | 152.99K | 88.92K | 100.87K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 32.48% | 25.10% | 25.20% | 52.24% | 39.68% | 15.30% | 10.16% | 10.19% | 2.16% | 4.18% | 18.25% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 52.04M | 46.99M | 24.41M | 43.83M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 28.99K | 16.44K | 17.33K |
| Selling & Marketing | 2.12M | 1.27M | 190.00K | 1.49M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 54.16M | 48.26M | 24.60M | 45.32M | 43.30M | 25.36M | 20.72M | 9.83M | 18.33M | 3.58M | 1.07M | 28.99K | 16.44K | 17.33K |
| Other Expenses | 156.50M | -433.00K | 964.00K | 144.00K | 0.00 | 565.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 210.66M | 48.26M | 24.60M | 45.32M | 43.30M | 25.36M | 20.72M | 9.83M | 18.33M | 3.58M | 1.07M | 28.99K | 16.44K | 17.33K |
| Cost & Expenses | 245.78M | 83.96M | 35.29M | 58.72M | 62.20M | 55.68M | 43.48M | 18.79M | 25.27M | 5.61M | 1.52M | 28.99K | 16.44K | 17.33K |
| Interest Income | 4.17M | 1.78M | 1.39M | 9.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 4.17M | 1.78M | 2.93M | 9.30M | 13.09M | 2.68M | 1.79M | 1.17M | 1.10M | 1.28M | 62.20K | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 13.40M | 8.96M | 964.00K | 6.29M | 4.98M | 3.65M | 2.54M | 645.29K | 438.78K | 41.31K | 14.09K | 0.00 | 0.00 | 0.00 |
| EBITDA | -193.76M | -29.15M | -12.76M | -39.29M | -24.48M | -16.23M | -18.15M | -8.17M | -17.74M | -3.45M | -957.91K | -28.99K | -16.44K | -17.33K |
| EBITDA Ratio | -372.51% | -57.33% | -140.25% | -86.91% | -84.74% | -45.34% | -71.65% | -81.92% | -250.00% | -162.08% | -173.35% | 0.00% | 0.00% | 0.00% |
| Operating Income | -193.76M | -36.29M | -21.00M | -30.67M | -30.87M | -19.88M | -18.15M | -8.82M | -18.17M | -3.49M | -5.77M | -28.99K | -16.44K | -17.33K |
| Operating Income Ratio | -372.51% | -76.12% | -147.00% | -109.33% | -98.52% | -55.53% | -71.65% | -88.39% | -256.19% | -164.03% | -1,044.55% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -1.87M | -5.89M | -9.12M | -17.77M | -8.60M | -13.65M | -9.84M | -546.10K | -3.99M | -2.66M | -63.53K | 0.00 | 0.00 | 0.00 |
| Income Before Tax | -195.63M | -42.18M | -13.80M | -48.44M | -39.47M | -33.53M | -27.99M | -9.36M | -22.17M | -6.15M | -5.84M | -28.99K | -16.44K | -17.33K |
| Income Before Tax Ratio | -376.11% | -88.47% | -96.59% | -172.70% | -125.98% | -93.66% | -110.49% | -93.86% | -312.46% | -289.14% | -1,056.05% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | -2.78M | 885.00K | 13.04M | 6.87M | 279.61K | -347.46K | -1.07M | 44.00K | 13.46K | 1.65K | 879.00 | 28.99K | 16.44K | 17.33K |
| Net Income | -192.85M | -43.06M | -26.84M | -55.31M | -39.75M | -32.68M | -26.92M | -9.23M | -21.89M | -6.15M | -5.84M | -28.99K | -16.44K | -17.33K |
| Net Income Ratio | -370.76% | -90.33% | -187.88% | -197.17% | -126.87% | -91.28% | -106.28% | -92.48% | -308.55% | -289.22% | -1,056.21% | 0.00% | 0.00% | 0.00% |
| EPS | -0.33 | -0.11 | -0.14 | -0.52 | -0.56 | -0.71 | -0.93 | -0.52 | -1.88 | -0.93 | -1.14 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.33 | -0.11 | -0.14 | -0.52 | -0.56 | -0.71 | -0.93 | -0.52 | -1.88 | -0.93 | -1.14 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 589.55M | 376.63M | 191.98M | 106.04M | 71.03M | 46.07M | 28.84M | 17.79M | 11.62M | 6.60M | 5.13M | 79.69M | 100.18M | 100.00M |
| Weighted Avg Shares Out (Dil) | 589.55M | 376.63M | 191.98M | 106.04M | 71.03M | 46.07M | 28.84M | 17.79M | 11.62M | 6.60M | 5.13M | 79.69M | 100.18M | 100.00M |
Unrivaled Brands Announces Management Agreement Pursuant to Acquisition of People's First Choice
Management Agreement is Now Effective, Granting Operational Control to Unrivaled Brands Management Agreement is Now Effective, Granting Operational Control to Unrivaled Brands
Unrivaled Brands Issues UMBRLA Audits and Pro Forma Results Following Close of Merger on July 1st
Combined Annualized Revenue of $66.3 Million Based on the Three Months Ended March 31, 2021 Combined Annualized Revenue of $66.3 Million Based on the Three Months Ended March 31, 2021
Unrivaled Expands Offering Through Exclusive Distribution Agreement with G-Eazy's FlowerShop* Lifestyle and Wellness Brand
SANTA ANA, Calif., Aug. 18, 2021 (GLOBE NEWSWIRE) -- Unrivaled Brands, Inc. (OTCQX:UNRV) ("Unrivaled" or the "Company") announced that it has entered into an exclusive agreement with Feel Better LLC (Feel Better) and their licensing and production partner Halo Collective...
Unrivaled Brands Reports Second Quarter 2021 Financial Results
Reports Top Line Year Over Year Quarterly Revenue Growth of 131% Reports Top Line Year Over Year Quarterly Revenue Growth of 131%
Unrivaled Brands, Inc. Announces Successful Sale of 4th Street Property in Las Vegas
SANTA ANA, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Unrivaled Brands, Inc., (OTCQX:UNRV) ("Unrivaled" or the "Company"), a multi-state vertically integrated company focused on the cannabis sector with operations in California, Oregon and Nevada, today announced that the Company has...
Unrivaled Brands, Inc. To Report Second Quarter 2021 Financial Results
SANTA ANA, Calif., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Unrivaled Brands, Inc., (OTCQX:UNRV) ("Unrivaled" or the "Company"), a multi-state vertically integrated company focused on the cannabis sector with operations in California, Oregon and Nevada, today announced that the Company will...
Unrivaled Cannabis (Podcast Transcript)
Unrivaled Cannabis (Podcast Transcript)
Source: https://incomestatements.info
Category: Stock Reports